AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from tomorrow onwards: Sources

According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine.

migrator

Updated:14th Jun, 2021 at 3:58 PM

New Delhi

The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.

According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine. After the recruitment of 6-12 yr old children AIIMS Delhi will be conducting trials for the age group 2-6 yr old. The trails are taking place at 525 centres.

AIIMS Patna, Mysore Medical College and Reaserch Institute in Karnataka have also been selected to conduct clinical trials on children. "We have started recruitment for children aged 6-12 years. Recruitments for clinical trails on children aged 12-18 years is over. They will be kept under observation." said Prabhat Kumar Singh, Director, AIIMS, Patna.

AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from tomorrow onwards: Sources

According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine.

Also Read

Cyclone Murasu: NDRF teams from Chennai rushed to Andhra Pradesh

Cyclone Murasu: TN rushes 500 electricity dept personnel, equipment to AP to restore power

DMK chief Stalin slams TVK govt over GST slump, loss of Rs 1,614 crore Korean investment to AP

SC dismisses petition filed by former DMK minister Nehru in cash-for-job scam

Pakistan suffered USD 40 bn in economic losses due to suspension of trade with India: PIBC chief